Cognitive decline is believed to be associated with neurodegenerative processes involving
excitotoxicity, oxidative damage, inflammation, and microvascular and blood-brain barrier …

In this study, we investigated whether treatment with palmitoylethanolamide and luteolin
(PEA-LUT) leads to improvement in the quantitative or qualitative measures of olfactory …

Increasing evidence strongly supports the key role of neuroinflammation in the
pathophysiology of neurodegenerative diseases, such as Alzheimer's disease …

Long COVID is a recognized post-viral syndrome characterized by neurological, somatic
and neuropsychiatric symptoms that might last for long time after SARS-CoV-2 infection. An …

Chemotherapy-induced peripheral neuropathy (CIPN) is a common complication of
antineoplastic drugs, particularly paclitaxel (PTX). It can affect the quality of patients' lives …

Multiple sclerosis (MS) is a complex neurodegenerative disease. Although its pathogenesis
is rather vague in some aspects, it is well known to be an inflammatory process …

Transient receptor potential vanilloid 1 (TRPV1) is a transmembrane and non-selective
cation channel protein, which can be activated by various physical and chemical stimuli …

The lysosomal cysteine hydrolase N-acylethanolamine acid amidase (NAAA) deactivates
palmitoylethanolamide (PEA), a lipid-derived PPAR-α agonist that is critically involved in the …

Background Neuroinflammation is involved in the progression of Parkinson's disease (PD),
and N-acylethanolamine acid amidase (NAAA) is involved in regulating inflammation by …

Acute ischemic stroke (AIS), which represents 87% of all strokes, is caused by reduced
blood supply to the brain associated with a prolonged inflammatory process that …